4,939 ViewsCabozantinib is an oral small molecule inhibitor of melanoma and medullary tumor. It’s a lipophilic (fat-loving) inhibitor of the tyrosine-kinase catalyzing enzyme c-Met; it inhibits AXL andRET, too. The drug has also been shown to lower cholesterol and blood pressure levels. Cabozantinib such as Ceritinib(LDK378) is marketed under the trade names Cometriq, Cabometyx, and …
